Uniquely Conformed Peptide-Containing β2-Microglobulin- Free Heavy Chains of HLA-B2705 on the Cell Surface1

The human class I MHC molecules are known to generally exist on the cell surface either as peptide-containing complexes of H chain (α-chain) and β2-microglobulin (β2m) or as β2m-free H chains incapable of binding peptides. In this study, a uniquely conformed peptide-containing β2m-free HLA-B2705 H chain has been isolated using the recently described highly efficient perfusion-affinity chromatography system for purification of class I MHC protein molecules. This form recognized by the mAb MARB4 is very closely associated with the remainder of the peptide containing HLA-B2705/β2m complex reactive with mAb ME1 and is present to ∼1–10% of mAb ME1 reactive forms on the cell surface. Also, HLA-B2705 purified using the mAb ME1 affinity column includes this unique mAb MARB4-reactive, unusually stable peptide-containing β2m-free form. A peptide nonamer GRWRGWYTY was isolated and identified from this β2m-free HLA-B2705 H chain and was used to assemble the mAb MARB4 reactive form efficiently on the surface of cells expressing HLA-B2705. The discovery of this form opens new avenues for further investigation of the role of HLA-B27 in spondyloarthropathies.

[1]  V. Gnau,et al.  Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs , 2004, Immunogenetics.

[2]  E. Camafeita,et al.  The Cys-67 Residue of HLA-B27 Influences Cell Surface Stability, Peptide Specificity, and T-cell Antigen Presentation* , 2001, The Journal of Biological Chemistry.

[3]  D. Rognan,et al.  Mutation of Cys-67 Alters the Thermodynamic Stability of the Human Leukocyte Antigen HLA-B*2705* , 2001, The Journal of Biological Chemistry.

[4]  S. Demaria,et al.  Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. , 2000, Human immunology.

[5]  D. Witte,et al.  Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. , 2000, Arthritis and rheumatism.

[6]  C. Seitz,et al.  Structurally diverse forms of HLA-B27 molecules are displayed in vivo in a cell type-dependent manner. , 2000, Human immunology.

[7]  J. Strominger,et al.  Perfusion chromatography for very rapid purification of class I and II MHC proteins. , 2000, Journal of immunological methods.

[8]  N. Fernández,et al.  Human major histocompatibility molecules have the intrinsic ability to form homotypic associations. , 1999, Human immunology.

[9]  H. Rammensee,et al.  Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. , 1999, Journal of immunology.

[10]  S. Demaria,et al.  Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinase. , 1999, Human immunology.

[11]  A. McMichael,et al.  The role of HLA-B27 in spondyloarthritis , 1999, Immunogenetics.

[12]  R. Hammer,et al.  Inflammatory disease in HLA‐B27 transgenic rats , 1999, Immunological reviews.

[13]  J. Strominger,et al.  Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody. , 1999, Tissue antigens.

[14]  A. McMichael,et al.  Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. , 1999, Journal of immunology.

[15]  C. López-Larrea,et al.  The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. , 1998, Molecular medicine today.

[16]  A. Rickinson,et al.  HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27:peptide complex. , 1998, Journal of immunology.

[17]  H. Luthra,et al.  HLA-B27 and other predisposing factors in spondyloarthropathies. , 1998, Current opinion in rheumatology.

[18]  P. Cresswell,et al.  HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. , 1998, Immunity.

[19]  H. Luthra,et al.  Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. , 1998, Journal of immunology.

[20]  H. Rammensee,et al.  Naturally occurring A pocket polymorphism in HLA-B*2703 increases the dependence on an accessory anchor residue at P1 for optimal binding of nonamer peptides. , 1997, Journal of immunology.

[21]  R. Gibbs,et al.  Large-scale concatenation cDNA sequencing. , 1997, Genome research.

[22]  E Y Jones,et al.  MHC class I and class II structures. , 1997, Current opinion in immunology.

[23]  V. Engelhard,et al.  Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies. , 1996, Journal of immunology.

[24]  H. Luthra,et al.  Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies , 1995, The Journal of experimental medicine.

[25]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[26]  William Arbuthnot Sir Lane,et al.  A subset of HLA-B27 molecules contains peptides much longer than nonamers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Wang,et al.  A monoclonal antibody that recognizes HLA-B27 in the context of peptides. , 1994, Journal of immunology.

[28]  V. Engelhard,et al.  Structure of peptides associated with class I and class II MHC molecules. , 1994, Annual review of immunology.

[29]  Dean R. Madden,et al.  The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.

[30]  M. Bix,et al.  Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells , 1992, The Journal of experimental medicine.

[31]  S. Demaria,et al.  The origin and fate of β2m-free MHC class I molecules induced on activated T cells , 1992 .

[32]  Maria L. Wei,et al.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides , 1992, Nature.

[33]  P. Parham,et al.  The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. , 1992, Journal of immunology.

[34]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[35]  D. R. Madden,et al.  The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.

[36]  K. Rock,et al.  Dissociation of β 2-microglobulin leads to the accumulation of a substantial pool of inactive class I MHC heavy chains on the cell surface , 1991, Cell.

[37]  D. Kwiatkowski,et al.  HLA class I typing by PCR: HLA-B27 and an African B27 subtype , 1991, The Lancet.

[38]  H. Ploegh,et al.  HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. , 1990, International immunology.

[39]  A. van Leeuwen,et al.  Guilt by association: HLA-B27 and ankylosing spondylitis. , 1990, Immunology today.

[40]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[41]  J. Strominger,et al.  Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. , 1987, The Journal of biological chemistry.

[42]  J. Strominger,et al.  Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. , 1986, Cellular immunology.

[43]  H. Ploegh,et al.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.

[44]  P. Cresswell,et al.  Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.

[45]  A. McMichael,et al.  Recognition of HLA-B27 and related antigen by a monoclonal antibody. , 1982, Human immunology.

[46]  P. Parham,et al.  Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. , 1982, Journal of immunology.

[47]  W. Bodmer,et al.  Characterization of a monoclonal anti‐β2‐microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens , 1979, European journal of immunology.

[48]  C. Barnstable,et al.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. , 1979, Journal of immunology.

[49]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[50]  J. Strominger,et al.  Submit and disulfide structure of monomeric and dimeric forms of detergent-soluble HLA antigens. , 1977, The Journal of biological chemistry.

[51]  R D Sturrock,et al.  Ankylosing spondylitis and HL-A 27. , 1973, Lancet.

[52]  P I Terasaki,et al.  High association of an HL-A antigen, W27, with ankylosing spondylitis. , 1973, The New England journal of medicine.

[53]  T. Lund,et al.  Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis. , 1992, Annals of the rheumatic diseases.